Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
Conditions
Acute Myeloid Leukemia · Essential Thrombocythemia · Myelodysplastic Syndrome · Myelodysplastic/Myeloproliferative Neoplasm · Myeloproliferative Neoplasm · Myeloproliferative Neoplasm, Not Otherwise Specified · Polycythemia Vera · Primary Myelofibrosis · Secondary Myelofibrosis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Contact: Principal Investigator (Anna Halpern)
Study leads
Anna Halpern
Principal Investigator
Fred Hutch/University of Washington Cancer Consortium